BPC-157 Research Overview: Healing, Recovery & What the Studies Show
A deep-dive into BPC-157 research, covering mechanisms of action, animal study data on healing and recovery, and what researchers look for when evaluating this peptide.
What Is BPC-157?
BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a sequence found in human gastric juice. It consists of 15 amino acids and was first isolated by researchers studying gastric acid's role in tissue protection.
Unlike many peptides that require refrigeration, BPC-157 is notable for its stability in gastric acid and its apparent pleiotropic (multi-system) activity in preclinical models.
Key Research Findings
Tendon and Ligament Studies
Some of the most replicated BPC-157 research involves tendon and ligament injury models. Studies in rodents have repeatedly shown accelerated recovery of:
- Achilles tendon transections
- Medial collateral ligament injuries
- Quadriceps tendon damage
The proposed mechanism involves upregulation of the tendon-to-bone healing pathway, particularly through modulation of the VEGFR2-Akt-eNOS signaling cascade.
Gastrointestinal Research
BPC-157 was originally studied in the context of gut protection. Research has shown potential protective effects against:
- NSAID-induced gastric ulcers
- Intestinal anastomosis healing
- Inflammatory bowel models
Neurological Studies
A growing body of preclinical research has examined BPC-157's interactions with the central nervous system, including effects on dopamine and serotonin systems in animal models.
How It Is Typically Dosed in Studies
In rodent research, BPC-157 is commonly studied at doses between 10–100 mcg/kg body weight. Routes include subcutaneous injection, intraperitoneal injection, and oral administration.
Human equivalent dosing is not established, as BPC-157 has not been through clinical trials.
What Researchers Look For
When evaluating BPC-157 studies, experienced researchers typically note:
- Route of administration — results vary between injection and oral
- Model relevance — most evidence is from rodent injury models
- Dose-response data — whether researchers tested multiple doses
- Funding and independence — who sponsored the research